Fecal microbiota transplant improved or alleviated symptoms in 70% of patients with refractory irritable bowel syndrome, a small retrospective study has determined.
A single transfusion of fresh...
Maintenance treatment with infliximab beyond 1 year after ileocolonic resection for Crohn’s disease was associated with reduced recurrence in a prospective, open-label long-term follow-up...
Vedolizumab was not superior to placebo for inducing remission at 6 weeks in patients with Crohn’s disease who failed to respond to anti–tumor necrosis factor therapy, according to findings from the...
A gluten-free diet benefited asymptomatic patients with serologic markers for celiac disease in a prospective randomized study.
The findings support active screening for celiac disease in patients...
Finding healthy stool donors for fecal transplant may be a tough prospect.
That’s what Australian researchers have discovered in the course of the <link...
Fecal microbiota transplantation successfully treated severe and/or complicated Clostridium difficile infection in a retrospective, multicenter, long-term follow-up study of 17 patients in...
Patients in Norway who underwent removal of low-risk colorectal adenomas but did not get further colonoscopic surveillance showed a 25% lower risk of death from colorectal cancer 8 years later,...
SAN FRANCISCO – The indication for liver transplant, the selection of immunosuppression therapy, and smoking status influence the long-term risk of new solid organ malignancies after liver...
Coronary artery disease may develop at a younger age in patients with inflammatory bowel disease, even when they have fewer traditional risk factors for heart problems.
A database review of...
A substantial proportion of older adults in the United States undergo unnecessary and even harmful screening for colon, prostate, breast, and cervical cancer, contrary to clear guidelines that are...
